HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pneumothorax in cystic fibrosis.

AbstractBACKGROUND:
Spontaneous pneumothorax is a complication that is commonly reported in patients with cystic fibrosis (CF). An understanding of the pathophysiology of this complication and its consequences is important for the management of patients with CF.
OBJECTIVE:
To identify risk factors associated with pneumothorax and to determine the prognosis of CF patients following an episode of pneumothorax.
DESIGN:
A retrospective observational cohort study of the National Cystic Fibrosis Patient Registry between the years 1990 and 1999.
PATIENTS:
The registry contained data on 28,858 patients with CF who had been followed up over those 10 years at CF centers across the United States.
RESULTS:
Pneumothorax occurred with an average annual incidence of 0.64% and in 3.4% of patients overall. There was no increased occurrence by sex, but CF was more prevalent in older patients (mean [+/- SD] age, 21.9 +/- 9.1 years) with more severe pulmonary impairment (nearly 75% of patients with FEV1 of < 40% predicted). The principal risks associated with an increased occurrence of pneumothorax included the presence of Pseudomonas aeruginosa (odds ratio [OR], 2.3), Burkholderia cepacia (OR, 1.8), or Aspergillus (OR, 1.3) in sputum cultures, FEV1 < 30% predicted (OR, 1.5), enteral feeding (OR, 1.7), Medicaid insurance (OR, 1.1), pancreatic insufficiency (OR, 1.4), allergic bronchopulmonary aspergillosis (OR, 1.5), and massive hemoptysis (OR, 1.4). There is an increased morbidity (eg, increased number of hospitalizations and number of days spent in the hospital) and an increased 2-year mortality rate following pneumothorax.
CONCLUSION:
Pneumothorax is a serious complication in CF patients, occurring more commonly in older patients with more advanced lung disease. Nearly 1 in 167 patients will experience this complication each year. There is an attributable mortality to the complication and considerable morbidity, resulting in increased health-care utilization and a measurable decline in lung function.
AuthorsPatrick A Flume, Charlie Strange, Xiaobu Ye, Myla Ebeling, Thomas Hulsey, Leslie L Clark
JournalChest (Chest) Vol. 128 Issue 2 Pg. 720-8 (Aug 2005) ISSN: 0012-3692 [Print] United States
PMID16100160 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cystic Fibrosis (complications)
  • Female
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Pneumothorax (epidemiology, etiology)
  • Prognosis
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: